Darden Wealth Group’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$633K Hold
4,539
0.32% 71
2025
Q4
$557K Sell
4,539
-100
-2% -$12.2K 0.27% 76
2025
Q3
$515K Hold
4,639
0.27% 79
2025
Q2
$514K Buy
4,639
+206
+5% +$21.9K 0.31% 69
2025
Q1
$497K Buy
4,433
+13
+0.3% +$1.34K 0.39% 58
2024
Q4
$408K Hold
4,420
0.27% 70
2024
Q3
$371K Sell
4,420
-92
-2% -$7.02K 0.27% 70
2024
Q2
$310K Sell
4,512
-1,623
-26% -$108K 0.19% 79
2024
Q1
$449K Sell
6,135
-1,002
-14% -$77K 0.35% 66
2023
Q4
$578K Buy
+7,137
New +$555K 0.56% 51

Other funds holding GILD

Darden Wealth Group's GILD Position: Q1 2026 in Review

Darden Wealth Group held its Gilead Sciences (GILD) position steady in Q1 2026 at 4,539 shares worth $633K. The position accounts for 0.32% of the portfolio, ranked #71.

Darden Wealth Group first reported a position in GILD in Q4 2023 and has held it in 10 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Darden Wealth Group held 4,539 shares of Gilead Sciences worth $633K as of Q1 2026.
  • Darden Wealth Group left its Gilead Sciences share count unchanged in Q1 2026.
  • Gilead Sciences made up 0.32% of Darden Wealth Group's portfolio in Q1 2026, its #71 holding.
  • Darden Wealth Group first reported a position in Gilead Sciences in Q4 2023 and has held it in 10 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Darden Wealth Group's 13F filing for Q1 2026, filed 8 May 2026.